Omixon Founder, Attila Berces Returns as CEO, Aims to Roll-Out New Products

BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) April 20, 2020 Global molecular diagnostics company Omixon, headquartered in Budapest with US offices in Cambridge, MA, announced today that Omixon’s founder and chairman Dr. Attila Berces returns as CEO. Outgoing CEO Dr. Peter Meintjes led the e…

Source link

Related posts

Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer


Malicious brain cell identified


The 29th Mammalian Genetics and Development Workshop


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World